A multimodal intervention using nonopioid analgesics results in reduced intravenous opioid (IVOPI) exposure, length of stay (LOS), and 30-day readmission rates for hospitalized patients with inflammatory bowel disease (IBD), a study has shown.
Infection with Helicobacter pylori is associated with a higher risk of developing advanced colorectal neoplasia (AN), reports a study. Such correlation is consistent in both serological and histologic assessments of H. pylori infection.
Two doses of the novel potassium‐competitive acid blocker tegoprazan show comparable healing effects on gastric ulcers as lansoprazole, while having a favourable safety profile, according to the results of a phase III trial.
Patients with Crohn’s disease risk developing osteoporosis and related fractures, but this may be countered by performing combined impact and resistance training exercises, which confer benefits for bone mineral density and muscle function, a study has shown.
Reductions in liver fat and adipose tissue volumes were sustained in patients with type 2 diabetes (T2D) with the addition of the SGLT-2* inhibitor dapagliflozin (DAPA) and the DPP-4** inhibitor saxagliptin (SAXA) to metformin (MET), compared with a regimen comprising glimepiride (GLIM)+MET, according to the extension period results of a phase IIIb trial.